Abstract Archives of the RSNA, 2004
Scientific Papers — Nuclear Medicine,
Presented on December 2, 2004
Participants
Sub-Events
SSQ22-01 |
18F-FDG PET Improves Diagnostic Accuracy in Patients with Hürthle Cell Carcinoma Steven Larson MD | Heiko Schoder MD | Daniel Pryma MD | Henry Yeung | Richard Robbins MD |
SSQ22-02 |
F-18 FDG in Vitro Labeled Autologous Hyman Leukocytes versus In-111 Labeled Leukocytes for Evaluation of Suspected Orthopedic Infections Christopher Palestro MD | Gene Tronco MD | Josephine Rini MD | Hugh Richardson DPM | Russell Caprioli DPM | Kuldeep Bhargava PhD |
SSQ22-03 |
Whole-Body PET/CT in Staging of Newly Diagnosed Malignant Melanoma: Initial Results Hilmar Kuehl MD | Patrick Veit MD | Gerald Antoch MD | Florian Vogt MD | Robert Jablonka MD | Andreas Gutzeit MD |
SSQ22-04 |
Coregistered PET-CT in Restaging of Differentiated Thyroid Cancer: Comparison to PET Alone Holger Strunk MD | Holger Palmedo MD | Hans Schild | Ursula Jaeger MD | Niclas Hortling MD | Susanne Meyka MD | Hans-Jürgen Biersack MD |
SSQ22-05 |
Value of Integrated FDG PET/CT for Assessment of Persistent Ovarian Cancer Alessandro Del Maschio MD | Cristina Messa MD | Sandro Sironi MD | Barbara Zangheri | Giorgia Mangili | Ferruccio Fazio |
SSQ22-06 |
Fluorodeoxyglucose (FDG) Uptake Pattern in Splenic Lymphoma Pramod Gupta MD | Fabio Ponzo MD | Elissa Kramer MD | Erich Lee | Karen Mourtzikos MD |
SSQ22-07 |
An Analysis of Physiological FDG Uptake in the Rectum at PET/CT Richard Wahl MD | Takayoshi Ishimori MD | Samuel Pak MD |
SSQ22-08 |
Presurgical Comparison of PET, Integrated PET/CT, and Software Image Fusion in Patients with Non-Small Cell Lung Cancer Osman Ratib MD | Benjamin Halpern MD | Barbara Fueger MD | Wolfgang Weber MD | Christiaan Schiepers MD | Johannes Czernin MD |
SSQ22-09 |
Malignant Pleural Mesothelioma: Response Evaluation with Integrated PET-CT Imaging Hans Steinert | Marcia Santos Dellea MD | Thomas Hany MD | Monika Jermann MD | Marc Küng MD | Rolf Stahel MD |
Cite This Abstract